Thank you for your interest in the Hematology-Oncology Fellowship Program at Duke University Medical Center.
We will begin reviewing applications on December 1, 2009.
The deadline for review of applications is January 15, 2010. We encourage you to submit your applications to ERAS as early as possible
- Personal statement describing your long term career goals and plans for research in as much detail as possible
- Three letters of recommendation. Letters of reference should be provided by at least three individuals
- One letter must be provided by your Department of Medicine Chair and Residency Program Director
- Additional letters should be provided by two other individuals who know you well.
- Medical Student Performance Evaluation (MSPE)/Dean's letter
- Medical school transcript
- USMLE scores
- Wallet-sized color photo (optional)
Following the initial review of the completed application, some applicants will be invited for interviews.
In general, a visit to Duke is necessary for acceptance into the program. Exceptional circumstances that prevent a personal visit to Duke should be noted on the application form, in order for alternate arrangements to be attempted. Applicants who are invited to interview at Duke will be asked to provide the following information by e-mail:
- Two faculty members and/or programs that you are interested in visiting with
- Updated curriculum vitae (MS Word or PDF)
- Reprints of publications (PDFs, if available)
It is our policy to select fellows solely on the basis of qualifications and independent of race, sex, or national origin. However, funds to support the second and third years of the fellowship program are primarily obtained from the National Institutes of Health (NIH). These funds are restricted by the NIH to applicants who are U.S. citizens or who have immigrant (permanent residency) status. Candidates who do not meet these criteria will be considered if they are fully funded by their government or medical school.
The Duke University Hospital USMLE (or equivalent licensing examinations) Policy requires that all graduate medical trainees considered for entry into Duke University Hospital programs at the PGY3 level or higher must have passed Part 3 to be enrolled.
This site contains additional information on the fellowship and available clinical and research programs. If you have any questions, please direct telephone inquiries to Ms. Sarah Overaker, Fellowship Program Coordinator at 919-684-2287 between 9 a.m. and 3:30 p.m. Eastern time.
William H. Kane MD, PhD
Director, Hematology-Oncology Fellowship Program
Associate Professor of Medicine
Division of Hematology
Duke University Medical Center